<?xml version='1.0' encoding='iso-8859-1' ?>
<documents><document>
<title>CD43 modulates severity and onset of experimental autoimmune encephalomyelitis.</title>
<publication-date>2003-12-01T00:00:00-08:00</publication-date>
<state>published</state>
<authors>
<author>
<email>tonami@utk.edu</email>
<institution>University of Tennessee - Knoxville</institution>
<lname>Onami</lname>
<fname>Thandi</fname>
<mname>M.</mname>
</author>
<author>
<lname>Ford</lname>
<fname>M.</fname>
<mname>L.</mname>
</author>
<author>
<lname>Sperling</lname>
<fname>A.</fname>
</author>
<author>
<lname>Ahmed</lname>
<fname>R.</fname>
</author>
<author>
<lname>Evavold</lname>
<fname>B.</fname>
<mname>D.</mname>
</author>
</authors>
<disciplines><discipline>Immune System Diseases</discipline>
<discipline>Immunity</discipline>
<discipline>Immunology and Infectious Disease</discipline>
<discipline>Immunology of Infectious Disease</discipline>
<discipline>Immunopathology</discipline>
<discipline>Life Sciences</discipline>
<discipline>Medicine and Health Sciences</discipline>
<discipline>Microbiology</discipline>
<discipline>Virus Diseases</discipline>
</disciplines><abstract>&lt;p&gt;Experimental autoimmune encephalomyelitis (EAE) is a mouse model of multiple sclerosis characterized by infiltration of activated CD4(+) T lymphocytes into tissues of the CNS. This study investigated the role of CD43 in the induction and progression of EAE. Results demonstrate that CD43-deficient mice have reduced and delayed clinical and histological disease severity relative to CD43(+/+) mice. This reduction was characterized by decreased CD4(+) T cell infiltration of the CNS of CD43(-/-) mice but similar numbers of Ag-specific T cells in the periphery, suggesting a defect in T cell trafficking to the CNS. The absence of CD43 also affected cytokine production, as myelin oligodendrocyte glycoprotein (MOG) 35-55-specific CD43(-/-) CD4(+) T cells exhibited reduced IFN-gamma and increased IL-4 production. CD43(-/-) CD4(+) MOG-primed T cells exhibited reduced encephalitogenicity relative to CD43(+/+) cells upon adoptive transfer into naive recipients. These results suggest a role for CD43 in the differentiation and migration of MOG(35-55)-specific T cells in EAE, and identify it as a potential target for therapeutic intervention.&lt;/p&gt;</abstract>
<fpage>6527</fpage>
<lpage>6533</lpage>
<coverpage-url>https://trace.tennessee.edu/utk_micrpubs/23</coverpage-url>
<fulltext-url>https://trace.tennessee.edu/cgi/viewcontent.cgi?article=1023&amp;amp;context=utk_micrpubs&amp;amp;unstamped=1</fulltext-url>
<label>23</label>
<document-type>article</document-type>
<type>article</type>
<articleid>1023</articleid>
<submission-date>2011-02-04T13:30:18-08:00</submission-date>
<publication-title>Microbiology Publications and Other Works</publication-title>
<context-key>3764012</context-key>
<submission-path>utk_micrpubs/23</submission-path>
<fields>
<field name="create_openurl" type="boolean">
<value>true</value>
</field>
<field name="publication_date" type="date">
<value>2003-12-01T00:00:00-08:00</value>
</field>
<field name="source_publication" type="string">
<value>Journal of Immunology</value>
</field>
</fields>
</document>
</documents>